[Thrombolytic agents and substances with "minor fibrinolytic" effect].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D004357:Drug Synergism; D004617:Embolism / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009539:Nicotinic Acids / Q000627:therapeutic use; D010958:Plasminogen / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D013431:Sulfates; D013923:Thromboembolism / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy
D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D011134:Polysaccharides; D013431:Sulfates; D010958:Plasminogen; D006493:Heparin; D013300:Streptokinase
Des agents thrombolytiques et des substances à action "fibrinolytique mineure".